Related Experiment Video
Updated: Mar 19, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Challenges for the implementation of an outpatient parenteral antimicrobial therapy clinic system in Mexico
Laura Nuzzolo-Shihadeh1, Adrián Camacho-Ortiz1
1Centro de Infusión de Antimicrobianos y Tratamiento de Enfermedades infecciosas (CIATI), Department of Infectious Diseases, University Hospital Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, México.
Abstract:
Outpatient parenteral antimicrobial therapy (OPAT) programs were developed to deliver intravenous antibiotics to patients who no longer require hospitalization. Since their introduction in the 1970s, OPAT services have expanded worldwide, providing benefits, such as reduced hospital stay, lower costs, and improved patient satisfaction. In Mexico, OPAT programs remain scarce, with only two known clinics nationwide. Most parenteral treatments occur in informal settings without standardized protocols or trained staff. Our institutional experience demonstrates that OPAT is feasible and well accepted, even among patients with limited financial and social resources. However, implementation across Latin America faces barriers, including infrastructure, funding, and workforce limitations. Advocacy for supportive policies and evidence of cost-effectiveness are critical to achieving long-term program sustainability. Caregiver education is essential and ensures appropriate communication of questions, concerns, and potential adverse events. Finally, every patient receiving OPAT must have access to clinical services, laboratory monitoring, and follow-up with a physician. Implementation of this type of strategies could enhance sustainability and access. This perspective discusses the challenges and potential solutions to establishing OPAT services in Mexico and countries with similar healthcare models.
Insights
Outpatient parenteral antimicrobial therapy (OPAT) is feasible and accepted in Mexico, despite limited resources. Challenges in Latin America include infrastructure and funding, requiring policy advocacy for sustainable OPAT programs.
Area of Science:
- Infectious Diseases
- Health Services Research
- Global Health
Background:
- Outpatient parenteral antimicrobial therapy (OPAT) offers benefits like reduced hospital stays and costs.
- OPAT services are globally established but scarce in Mexico, with most treatments occurring informally.
- Existing informal treatments lack standardized protocols and trained staff.
Purpose of the Study:
- To discuss the challenges and potential solutions for establishing OPAT services in Mexico and similar healthcare settings.
- To highlight the feasibility and acceptance of OPAT in resource-limited environments.
- To advocate for policies and evidence supporting OPAT program sustainability.
Main Methods:
- Review of institutional experience with OPAT in Mexico.
- Analysis of barriers to OPAT implementation in Latin America.
- Discussion of strategies for enhancing OPAT sustainability and access.
Main Results:
- OPAT is demonstrated to be feasible and well-accepted, even among patients with limited financial and social resources.
- Significant barriers to OPAT implementation in Latin America include infrastructure, funding, and workforce limitations.
- Caregiver education and access to clinical services, laboratory monitoring, and physician follow-up are crucial for successful OPAT.
Conclusions:
- Establishing sustainable OPAT programs in Mexico and Latin America requires addressing infrastructure, funding, and workforce challenges.
- Advocacy for supportive policies and demonstrating cost-effectiveness are critical for long-term OPAT program viability.
- Integrated strategies involving caregiver education and comprehensive clinical support are essential for enhancing OPAT access and sustainability.
More Related Videos
07:13Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
Related Concept Videos
Automated Microbial Diagnostics
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Acute Pyelonephritis II: Diagnostic Studies and Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations